Compounded Tirzepatide in Georgia, Prescribed Online

How tirzepatide gets prescribed in Georgia, online

Protocol MD serves patients in all 50 states, Georgia among them, and the whole thing happens from where you already are: you complete an assessment, a physician licensed in Georgia reads it, and a pharmacy ships to your Georgia address. Georgia is one of the few states whose medical board wrote down what that online encounter has to look like, and that rule shapes this page.

Three steps, in order. You complete the assessment covering your goals, your medical history and every medication and supplement you take. A physician licensed in Georgia reviews it, comes back for anything missing, and decides whether Georgia's examination standard can be met from what you submitted or whether a live visit has to happen first. If treatment is approved, a US-licensed 503A compounding pharmacy dispenses and ships it.

Your card is held at checkout and charged only after the physician approves. If the physician declines, the hold is released and you are not charged. Read this page with the source in mind, too: Protocol MD sells compounded tirzepatide and makes money when a patient starts treatment, which is exactly why the clinical decision belongs to an independent physician who is paid to review your file whichever way it goes.

Does Georgia require an in-person exam before a tirzepatide prescription?

Not a prior one, but Georgia sets a higher bar on the online encounter itself than most states do. The Composite Medical Board's Rule 360-3-.07 lists four alternative ways a prescriber can satisfy it, and only one of them has to be true: the Georgia-licensed practitioner has personally seen and examined you and is providing ongoing or intermittent care electronically; is acting at the request of a Georgia-licensed practitioner who has examined you; is acting at the request of a public health or child-protection body for the protection of a minor; or, the one that carries most online care, "is able to examine the patient using technology or peripherals that are equal or superior to an examination done personally by a provider within that provider's standard of care."

That last alternative is the whole question in Georgia, and it is a demanding one. An examination equal or superior to an in-person examination is a different thing from a form you filled in, and the rule nowhere mentions asynchronous or store-and-forward care. Georgia does define "store and forward" transfer, but it does so in the Telehealth Act's insurance provisions, which tell insurers what they must pay for rather than telling prescribers what counts as an examination. Importing that definition into the practice standard is a common mistake and it is not what the Board rule says.

The rule also requires a Georgia-licensed prescriber with your history available, documented records of the evaluation, and that the practitioner "make diligent efforts to have the patient seen and examined in person by a Georgia licensed physician, physician assistant or nurse practitioner at least annually." That is an effort standard rather than an absolute condition, and it is worth knowing about before you start: Georgia expects online care to stay connected to in-person care over time. Rule 360-3-.07 holds electronic practice to the same standard of care as in-person practice, and it does not authorize prescribing controlled substances for pain by electronic means at all.

Tirzepatide sits outside that last restriction. It is not scheduled under Georgia's controlled substance schedules and it is not a pain medication, so the controlled-substance limits in the rule do not reach it. What does reach it is the examination standard, and the Georgia-licensed physician reviewing your assessment is the person who decides how it is met for you.

Who prescribes it: a physician licensed in Georgia

Your location decides the license, not the physician's. Under O.C.G.A. section 43-34-31, someone physically located in another state who uses electronic means to perform an act that is part of a patient care service located in Georgia, and that would affect your diagnosis or treatment, is practicing medicine in Georgia and must hold a Georgia medical license or a Georgia telemedicine license. The statute's own exceptions are narrow: occasional consultation at a Georgia physician's request, emergencies, uncompensated consultations, and teaching at approved medical schools.

The telemedicine license is the one Georgia built for this, created by SB 115 in 2019 and codified at section 43-34-31.1. It requires a full and unrestricted license in another state and no disciplinary history elsewhere, and the Board's Rule 360-2-.17 limits it to the practice of telemedicine. Note what that rule also says, because almost nobody mentions it: a telemedicine licensee "must adhere to Rule 360-3-.07." There is no version of Georgia's licensing rules where the examination standard goes away.

Georgia is also a member of the Interstate Medical Licensure Compact, and the Board's compact page describes the expedited pathways. A compact license is still a Georgia license; it shortens the paperwork rather than removing the requirement. You can check any Georgia physician's licence status with the Composite Medical Board's Verify a Licensee tool, and if a telehealth company will not tell you which Georgia-licensed physician signed your prescription, that is an answer in itself.

This page was reviewed by Dr. Richard Dentico, MD. Clinical decisions for Georgia patients are made by the independent Georgia-licensed physicians in Protocol MD's affiliated provider network, not by Protocol MD.

What Georgia entitles you to from an online prescriber

Georgia's rule is unusual in that it writes down things the patient gets, not only things the prescriber must do. Under Rule 360-3-.07, a patient treated by electronic means must be given "the name, credentials and emergency contact information" for the Georgia-licensed physician, physician assistant or advanced practice registered nurse providing the treatment, and must be provided with "clear, appropriate, accurate instructions on follow-up in the event of needed emergent care related to the treatment." The rule defines credentials for a physician as the area of practice and training.

The practitioner must also maintain your records and document the evaluation and treatment along with the identity of whoever provided it. Taken together, those are a short list of questions worth asking any online provider serving Georgia: who exactly is prescribing, what are they trained in, how do I reach someone in an emergency, and where do my records live. A provider that cannot answer is telling you something about how it operates.

Who may be a candidate, and who should not take tirzepatide

Whether compounded tirzepatide fits you is the Georgia-licensed physician's judgment, built from your history, your current medications and what you are trying to change. It is a prescription medicine rather than a supplement, and being declined is a real outcome of the assessment rather than a formality designed to wave you through.

Some people should not take it at all. The brand-name tirzepatide label carries a boxed warning about thyroid C-cell tumors, so a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2) rules it out, and it is not used in pregnancy. Gastrointestinal effects are the common ones; our tirzepatide side effects guide covers what they look like and when to call a clinician.

Tirzepatide is given once weekly with the dose raised in steps under supervision, and what that means for you is a decision the prescribing physician makes with you. Nothing on this page is a dose to follow or a schedule to copy, and Protocol MD does not publish one. Protocol MD does not offer GLP-1 microdosing.

Bloodwork for Georgia patients

Georgia's rule has something to say here as well: Rule 360-3-.07 provides that nothing in it "shall excuse a physician, nurse practitioner or physician assistant from ordering appropriate laboratory or other diagnostic tests needed to make diagnoses within the minimum standard of care." Practising online does not lower the diagnostic bar in Georgia.

If bloodwork belongs in your plan, you order the panel yourself and the draw happens at Labcorp, which runs patient service centers across Georgia; Protocol MD does not use any other lab network. Your results land in your patient portal, and you get an email, usually within 3-5 business days of your draw. Which markers get run, and whether any of them are looked at again later, is your physician's clinical call rather than an interval Protocol MD publishes. No lab result is required before you start the assessment.

Who may ship compounded tirzepatide into Georgia

Georgia Board of Pharmacy Rule 480-6-.02 is blunt about it: since April 1, 2015 it has been unlawful for a pharmacy or facility located outside the state "to ship, mail, or deliver prescription drugs orders into this state or to advertise its services" without a Georgia pharmacy license or a nonresident pharmacy permit. Georgia regulates the advertising as well as the shipping, which is stricter than most states. The permit application requires proof of a valid, unexpired licence in every state where the applicant dispenses, and evidence that the pharmacist-in-charge is licensed and in good standing where they are located.

Georgia also gives you a phone number. Under O.C.G.A. section 26-4-114.1, a nonresident permit holder must maintain a toll-free telephone number, operational at least six days a week and not less than 60 hours a week, "used to provide and facilitate patient counseling," capable of receiving calls from patients, and printed on the label of every container dispensed into Georgia. If you are in Georgia, that number on your box is a right, not a courtesy.

Protocol MD prescriptions are filled by a US-licensed 503A compounding pharmacy; under Georgia law, a pharmacy shipping to you must hold the Georgia license or nonresident permit described here. Tirzepatide is an injectable, so what arrives is a sterile preparation compounded against your individual prescription, and Georgia's rules point pharmacies at the USP-NF standards for sterile and nonsterile compounding. If you are comparing Georgia providers, ask the blunt version of the question: which pharmacy fills it, and does that pharmacy hold a Georgia nonresident permit?

What compounded tirzepatide costs in Georgia

Protocol MD is cash-pay in Georgia. There is no membership fee, there is no insurer to bill, and compounded tirzepatide costs the same at every dose, so what you pay does not climb as the physician adjusts treatment. Current pricing lives on the product page rather than here, where it would go stale.

Comparing Georgia quotes is harder than it looks, because the quotes are not built the same way. Some include the physician review and the shipping; some add them afterwards; some are an introductory month that resets. Ask what a number covers before you set it beside another number.

Does Georgia Medicaid or the State Health Benefit Plan cover GLP-1 medications for weight loss?

Those two answers are different, which is where most Georgia confusion comes from. Pew Research Center's January 2026 chart, drawn from KFF's survey, places Georgia Medicaid in the "not covered" category for GLP-1s for obesity treatment. Georgia Medicaid's own fee-for-service preferred drug list is where to confirm the current status of any particular medication, and GLP-1 entries there have sat in the diabetes class with prior authorization rather than as weight-loss drugs.

The State Health Benefit Plan, which covers state employees, teachers and their families, is the opposite story and it changed this month. SHBP says that "effective October 1, 2026, participation in the 9amHealth program will be optional and no longer be required in order to obtain your weight loss medication," and that prescriptions "can be written by the member's physician of choice" from that date. Weight loss prescriptions still "must comply with prior authorization and benefit coverage rule requirements," members enrolled in one of the carriers are "currently not eligible," and SHBP says coverage requirements for the 2027 benefit year will come with open enrollment materials. If you are on SHBP, that is a conversation worth having with your own physician before you pay cash for anything.

None of it changes what you pay here, because Protocol MD does not bill Medicaid, SHBP or any other insurer, and compounded tirzepatide is not the brand-name product those formularies are written about.

What compounded tirzepatide is, and what it isn't

Tirzepatide is a single molecule acting on two incretin receptors, GIP and GLP-1, given once weekly under supervision. What Protocol MD ships is compounded by a US-licensed 503A pharmacy against an individual prescription, and it is an injection. There is no oral tirzepatide in the Protocol MD catalog, so if that is what you searched for, an injection is what this page describes.

Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety or effectiveness. The SURMOUNT trials studied the brand-name product, so neither those approvals nor those results carry across to a compounded preparation, and compounded tirzepatide is not a generic of or a substitute for any brand-name product. The brand-name products are the FDA-approved option and remain a reasonable thing to raise with any physician; the FDA's own guidance is that compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug. Weighing tirzepatide against the other GLP-1? Start with compounded semaglutide.